These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


179 related items for PubMed ID: 1328138

  • 21. In vitro activity of RP 59500, a semisynthetic injectable pristinamycin, against staphylococci, streptococci, and enterococci.
    Fass RJ.
    Antimicrob Agents Chemother; 1991 Mar; 35(3):553-9. PubMed ID: 1903912
    [Abstract] [Full Text] [Related]

  • 22. Effect of CO2 on susceptibilities of anaerobes to erythromycin, azithromycin, clarithromycin, and roxithromycin.
    Spangler SK, Jacobs MR, Appelbaum PC.
    Antimicrob Agents Chemother; 1994 Feb; 38(2):211-6. PubMed ID: 8192445
    [Abstract] [Full Text] [Related]

  • 23. In-vitro activity of RP 59500, a new synergic antibacterial agent, against Legionella spp.
    Dubois J, Joly JR.
    J Antimicrob Chemother; 1992 Jul; 30 Suppl A():77-81. PubMed ID: 1399954
    [Abstract] [Full Text] [Related]

  • 24. In vitro activity of YM133, a new semisynthesized macrolide.
    Terasawa T, Watanabe M, Okubo T, Mitsuhashi S.
    Antimicrob Agents Chemother; 1991 Jul; 35(7):1370-5. PubMed ID: 1929295
    [Abstract] [Full Text] [Related]

  • 25. Antimicrobial activity of josamycin against erythromycin-resistant staphylococci as compared to roxythromycin and clarithromycin.
    Guggenbichler JP, Georgopoulos A, Scharrer P, Kobilansky C, Mühlbacher J, Georgopoulos M, Dierich MP.
    Infection; 1993 Jul; 21(4):259-61. PubMed ID: 8225634
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. The in-vitro and disc susceptibility testing of clarithromycin and its 14-hydroxy metabolite.
    Logan MN, Ashby JP, Andrews JM, Wise R.
    J Antimicrob Chemother; 1991 Feb; 27(2):161-70. PubMed ID: 1829073
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Spectrum of activity of azithromycin.
    Williams JD.
    Eur J Clin Microbiol Infect Dis; 1991 Oct; 10(10):813-20. PubMed ID: 1662624
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Antimicrobial activities of roxithromycin against recently obtained clinical isolates].
    Igari J, Oguri T, Tachibana Y, Misawa N, Nakamura A, Shitara M, Umezu S, Nakamura Y, Tazawa S, Shimoura M, Ugajin K, Mori T, Shimada J, Kaku M, Murase M, Hirakata Y, Matsuda J.
    Jpn J Antibiot; 1997 Jul; 50(7):640-9. PubMed ID: 9743909
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. In vitro activities of a streptogramin (RP59500), three macrolides, and an azalide against four respiratory tract pathogens.
    Barry AL, Fuchs PC.
    Antimicrob Agents Chemother; 1995 Jan; 39(1):238-40. PubMed ID: 7695313
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. The in vitro activity of some 14-, 15- and 16- membered macrolides against Staphylococcus spp., Legionella spp., Mycoplasma spp. and Ureaplasma urealyticum.
    Felmingham D, Robbins MJ, Sanghrajka M, Leakey A, Ridgway GL.
    Drugs Exp Clin Res; 1991 Jan; 17(2):91-9. PubMed ID: 1650694
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.